2932-1357 Screening compound: 2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one

2932-1357 Screening compound: 2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one
2932-1357 Screening compound: 2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 2932-1357
2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2932-1357

Molecular Formula

C24H17F3N2O2S3 (C24 H17 F3 N2 O2 S3)

Compound Name

2-[(6-ethoxy-1,3-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one

IUPAC name

2-[(6-ethoxy-13-benzothiazol-2-yl)sulfanyl]-1-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]ethan-1-one

SMILES

CCOc(cc1)cc2c1nc(SCC(N1c(cc(C(F)(F)F)cc3)c3Sc3c1cccc3)=O)s2

InChI

InChI=1S/C24H17F3N2O2S3/c1-2-31-15-8-9-16-21(12-15)34-23(28-16)32-13-22(30)29-17-5-3-4-6-19(17)33-20-10-7-14(11-18(20)29)24(25,26)27/h3-12H,2,13H2,1H3

InChI Key

DGRGKBKAUASPNJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01796515

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

518.6

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

7.206

Distribution Coefficient, logD

7.206

Water Solubility, LogSw

-5.64

Polar Surface Area

29.547

Acid Dissociation Constant (pKa)

17.31

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

2932-1357 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2932-1357 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2932-1357?
Check Price and Availability of 2932-1357, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2932-1357 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2932-1357
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2932-1357
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2932-1357 available by request